리서치사:Market Glass, Inc. (Formerly Global Industry Analysts, Inc.)
발행일:2024년 08월
페이지 정보:영문 182 Pages
라이선스 & 가격 (부가세 별도)
한글목차
세계의 양수천자침 시장은 2030년까지 2억 1,300만 달러에 달할 전망
2023년에 1억 8,390만 달러로 추정되는 세계의 양수천자침 시장은 2030년에는 2억 1,300만 달러에 달하며, 분석 기간인 2023-2030년 CAGR은 2.1%로 성장할 것으로 예측됩니다. 본 리포트에서 분석한 부문의 하나인 150mm 이상의 바늘은 CAGR 2.4%를 기록하며, 분석 기간 종료까지 6,730만 달러에 달할 것으로 예측됩니다. 100-150mm니들 부문의 성장률은 분석 기간 중 CAGR 1.9%로 추정됩니다.
미국 시장은 4,860만 달러로 추정, 중국은 CAGR 2.0%로 성장 예측
미국의 양수천자침 시장은 2023년에 4,860만 달러로 추정됩니다. 세계 2위의 경제대국인 중국은 2030년까지 3,430만 달러의 시장 규모에 달할 것으로 예측되며, 분석 기간인 2023-2030년 CAGR은 2.0%입니다. 기타 주목해야 할 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간 중 CAGR은 각각 2.0%와 1.7%로 예측됩니다. 유럽에서는 독일이 CAGR 2.3%로 성장할 것으로 예측됩니다.
세계의 양수천자침 시장 - 주요 동향과 촉진요인 정리
왜 양수천자침은 임산부 케어에서 중요한가?
양수천자침은 산전 진단에서 양수를 채취하고 검사하는 데 사용되는 중요한 의료기기입니다. 이 검사는 태아의 염색체 이상, 유전 질환, 감염 등을 발견하는 데 도움이 되며, 임산부 부모와 의료진에게 귀중한 정보를 제공합니다. 일반적으로 양수 천자는 임신 15주에서 20주 사이에 시행되며, 초음파 검사를 통해 유도하면서 산모의 복부를 통해 양막낭에 미세한 바늘을 삽입합니다. 채취한 양수에는 태아의 세포와 아기가 생성하는 다양한 화학물질이 포함되어 있으며, 풍부한 진단 데이터를 얻을 수 있습니다. 이 바늘의 중요성은 정확성과 안전성에 있는데, 정확한 결과를 얻는 동시에 산모와 태아 모두에 대한 위험을 최소화해야 하기 때문입니다.
기술 혁신은 어떻게 양수천자침을 개선하고 있는가?
기술의 발전은 양수천자침의 디자인과 기능을 크게 향상 시켰습니다. 재료 과학의 혁신으로 더 얇고 유연하며 내구성이 뛰어난 바늘이 개발되어 환자의 불편함을 줄이고 합병증의 위험을 최소화합니다. 또한 초음파 기술의 발전으로 바늘 삽입의 정확도가 향상되어 시술의 안전성과 성공률이 높아졌습니다. 또한 일부 최신 양수천자침은 초음파 유도 하에서 가시성을 향상시키는 에코원성 마킹과 같은 기능을 갖춘 제품도 있습니다. 이러한 기술적 개선으로 양수 천자는 더욱 안전하고 신뢰할 수 있는 시술이 되어 산전 진료에서 양수 천자의 수용과 활용이 증가하고 있습니다.
규제 및 윤리적 고려사항은?
양수천자침의 사용은 시술의 안전성과 유효성을 보장하기 위해 엄격한 규제 기준의 적용을 받으며, FDA 및 EMA와 같은 규제기관은 이러한 의료기기의 승인 및 모니터링을 감독하여 엄격한 안전 및 품질 요구 사항을 충족하는지 확인합니다. 특히 태아에 대한 잠재적 위험과 검사 결과의 의미와 관련하여 윤리적 고려사항도 중요한 역할을 합니다. 사전 동의는 이 검사의 중요한 측면이며, 의료 서비스 프로바이더는 임산부 부모에게 이 검사의 장점, 위험 및 가능한 결과에 대해 철저하게 설명해야 합니다. 또한 비침습적 산전검사(NIPT)의 발전은 양수 천자 수요에 영향을 미치고 있습니다. 이러한 고려사항에도 불구하고 양수 천자는 여전히 중요한 산전 진단 툴로, 비침습적 방법으로는 얻을 수 없는 결정적인 진단 정보를 제공합니다.
양수천자침 시장 성장의 원동력은?
양수천자침 시장의 성장은 산모 연령 증가, 산전 진단에 대한 인식 증가, 의료기기 기술 발전 등 여러 요인에 기인합니다. 점점 더 많은 여성들이 늦은 나이에 아이를 갖기로 선택함에 따라 염색체 이상 발생률이 증가하여 양수 천자와 같은 신뢰할 수 있는 진단 절차에 대한 수요가 증가하고 있습니다. 더 얇고 유연한 바늘의 개발과 같은 기술 혁신은 시술의 안전성과 편안함을 향상시켜 그 채택을 촉진하고 있습니다. 또한 초음파 기술의 발전으로 보다 정확한 바늘 설치가 용이해져 시술의 성공률이 높아지고 있습니다. 임산부들 사이에서 산전 검사에 대한 인식과 수용도가 높아진 것도 시장 성장에 기여하고 있습니다. 또한 산전 관리 및 진단을 촉진하기 위한 정부의 구상과 의료 정책은 양수천자침 시장의 성장을 가속하는 환경을 조성하고 있습니다.
조사 대상 기업의 예(총 14건)
Becton, Dickinson and Company
Biopsybell Srl
Cook Medical LLC
CooperSurgical, Inc.
Integra LifeSciences Holdings Corporation
Laboratoire Ccd
Medline Industries, Inc.
Medtronic PLC
RI.MOS. Srl
Rocket Medical PLC
Smiths Medical
Tsunami Medical
목차
제1장 조사 방법
제2장 개요
시장 개요
주요 기업
시장 동향과 촉진요인
세계 시장의 전망
제3장 시장 분석
미국
캐나다
일본
중국
유럽
프랑스
독일
이탈리아
영국
기타 유럽
아시아태평양
기타 지역
제4장 경쟁
KSA
영문 목차
영문목차
Global Amniocentesis Needles Market to Reach US$213.0 Million by 2030
The global market for Amniocentesis Needles estimated at US$183.9 Million in the year 2023, is expected to reach US$213.0 Million by 2030, growing at a CAGR of 2.1% over the analysis period 2023-2030. 150 mm & Above Needles, one of the segments analyzed in the report, is expected to record a 2.4% CAGR and reach US$67.3 Million by the end of the analysis period. Growth in the 100 - 150 mm Needles segment is estimated at 1.9% CAGR over the analysis period.
The U.S. Market is Estimated at US$48.6 Million While China is Forecast to Grow at 2.0% CAGR
The Amniocentesis Needles market in the U.S. is estimated at US$48.6 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$34.3 Million by the year 2030 trailing a CAGR of 2.0% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.0% and 1.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.3% CAGR.
Global Amniocentesis Needles Market - Key Trends and Drivers Summarized
Why Are Amniocentesis Needles Important in Prenatal Care?
Amniocentesis needles are critical medical instruments used in prenatal diagnosis to collect amniotic fluid for testing. This procedure helps detect chromosomal abnormalities, genetic disorders, and infections in the fetus, providing invaluable information for expecting parents and healthcare providers. Typically performed between the 15th and 20th weeks of pregnancy, amniocentesis involves inserting a thin needle into the amniotic sac through the mother’s abdomen, guided by ultrasound. The collected fluid contains fetal cells and various chemicals produced by the baby, offering a wealth of diagnostic data. The importance of these needles lies in their precision and safety, as the procedure must minimize risk to both the mother and the fetus while yielding accurate results.
How Are Technological Innovations Enhancing Amniocentesis Needles?
Technological advancements are significantly improving the design and functionality of amniocentesis needles. Innovations in material science have led to the development of needles that are thinner, more flexible, and more durable, reducing discomfort for the patient and minimizing the risk of complications. Advances in ultrasound technology have also enhanced the accuracy of needle placement, increasing the safety and success rates of the procedure. Additionally, some modern amniocentesis needles come equipped with features such as echogenic markings that improve visibility under ultrasound guidance. These technological improvements are making amniocentesis a safer and more reliable procedure, thereby increasing its acceptance and usage in prenatal care.
What Are the Regulatory and Ethical Considerations?
The use of amniocentesis needles is subject to stringent regulatory standards to ensure the safety and efficacy of the procedure. Regulatory bodies such as the FDA and EMA oversee the approval and monitoring of these medical devices, ensuring they meet rigorous safety and quality requirements. Ethical considerations also play a significant role, particularly concerning the potential risks to the fetus and the implications of the test results. Informed consent is a crucial aspect of the procedure, with healthcare providers required to thoroughly explain the benefits, risks, and possible outcomes to the expectant parents. Additionally, advancements in non-invasive prenatal testing (NIPT) are influencing the demand for amniocentesis, as some parents may opt for less invasive screening methods. Despite these considerations, amniocentesis remains a vital tool in prenatal diagnosis, offering definitive diagnostic information that non-invasive methods cannot always provide.
What Is Driving Market Growth for Amniocentesis Needles?
The growth in the amniocentesis needles market is driven by several factors, including rising maternal age, increasing awareness of prenatal diagnostics, and technological advancements in medical devices. As more women are choosing to have children later in life, the incidence of chromosomal abnormalities increases, thereby boosting the demand for reliable diagnostic procedures like amniocentesis. Technological innovations, such as the development of thinner and more flexible needles, are enhancing the safety and comfort of the procedure, encouraging its adoption. Additionally, improved ultrasound technologies are facilitating more accurate needle placement, increasing the procedure's success rate. Growing awareness and acceptance of prenatal testing among expectant parents are also contributing to market growth, as more couples seek comprehensive information about their unborn child's health. Furthermore, government initiatives and healthcare policies promoting prenatal care and diagnostics are creating a supportive environment for the expansion of the amniocentesis needles market.
Select Competitors (Total 14 Featured) -
Becton, Dickinson and Company
Biopsybell Srl
Cook Medical LLC
CooperSurgical, Inc.
Integra LifeSciences Holdings Corporation
Laboratoire Ccd
Medline Industries, Inc.
Medtronic PLC
RI.MOS. Srl
Rocket Medical PLC
Smiths Medical
Tsunami Medical
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
Amniocentesis Needles - Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
Global Economic Update
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rising Maternal Age Spurs Growth in Prenatal Diagnostics, Driving Market Growth
Technological Innovations in Needle Design Propel Market Expansion
Increasing Awareness of Genetic Disorders Expands Addressable Market Opportunity
Advances in Ultrasound Technology Strengthen Business Case for Amniocentesis
Growing Acceptance of Prenatal Testing Drives Adoption of Amniocentesis Needles
Shift towards Minimally Invasive Procedures Throws the Spotlight On Amniocentesis
Increasing Healthcare Expenditure Accelerates Demand for Prenatal Care
Integration of Echogenic Markings in Needles Propels Growth
Rising Incidence of High-Risk Pregnancies Expands Addressable Market
Development of Non-Invasive Prenatal Testing (NIPT) Creates Challenges for Traditional Methods
Rising Demand for Comprehensive Fetal Health Information Generates Adoption
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Amniocentesis Needles by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
TABLE 2: World Historic Review for Amniocentesis Needles by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 3: World 16-Year Perspective for Amniocentesis Needles by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
TABLE 4: World Recent Past, Current & Future Analysis for Amniocentesis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
TABLE 5: World Historic Review for Amniocentesis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 6: World 16-Year Perspective for Amniocentesis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 7: World Recent Past, Current & Future Analysis for Amnioreduction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
TABLE 8: World Historic Review for Amnioreduction by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 9: World 16-Year Perspective for Amnioreduction by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 10: World Recent Past, Current & Future Analysis for Fetal Blood Transfusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
TABLE 11: World Historic Review for Fetal Blood Transfusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 12: World 16-Year Perspective for Fetal Blood Transfusion by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 13: World Recent Past, Current & Future Analysis for Amnioinfusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
TABLE 14: World Historic Review for Amnioinfusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 15: World 16-Year Perspective for Amnioinfusion by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 16: World Recent Past, Current & Future Analysis for Cordocentesis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
TABLE 17: World Historic Review for Cordocentesis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 18: World 16-Year Perspective for Cordocentesis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 19: World Recent Past, Current & Future Analysis for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
TABLE 20: World Historic Review for Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 21: World 16-Year Perspective for Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 22: World Recent Past, Current & Future Analysis for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
TABLE 23: World Historic Review for Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 24: World 16-Year Perspective for Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 25: World Recent Past, Current & Future Analysis for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
TABLE 26: World Historic Review for Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 27: World 16-Year Perspective for Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 28: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
TABLE 29: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 30: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 31: World Amniocentesis Needles Market Analysis of Annual Sales in US$ for Years 2014 through 2030
TABLE 32: World Recent Past, Current & Future Analysis for 150 mm & Above by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
TABLE 33: World Historic Review for 150 mm & Above by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 34: World 16-Year Perspective for 150 mm & Above by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 35: World Recent Past, Current & Future Analysis for 100 - 150 mm by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
TABLE 36: World Historic Review for 100 - 150 mm by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 37: World 16-Year Perspective for 100 - 150 mm by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 38: World Recent Past, Current & Future Analysis for Below 100 mm by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
TABLE 39: World Historic Review for Below 100 mm by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 40: World 16-Year Perspective for Below 100 mm by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
Amniocentesis Needles Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 41: USA Recent Past, Current & Future Analysis for Amniocentesis Needles by Type - 150 mm & Above, 100 - 150 mm and Below 100 mm - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 42: USA Historic Review for Amniocentesis Needles by Type - 150 mm & Above, 100 - 150 mm and Below 100 mm Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 43: USA 16-Year Perspective for Amniocentesis Needles by Type - Percentage Breakdown of Value Sales for 150 mm & Above, 100 - 150 mm and Below 100 mm for the Years 2014, 2024 & 2030
TABLE 44: USA Recent Past, Current & Future Analysis for Amniocentesis Needles by Procedure - Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion and Cordocentesis - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 45: USA Historic Review for Amniocentesis Needles by Procedure - Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion and Cordocentesis Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 46: USA 16-Year Perspective for Amniocentesis Needles by Procedure - Percentage Breakdown of Value Sales for Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion and Cordocentesis for the Years 2014, 2024 & 2030
TABLE 47: USA Recent Past, Current & Future Analysis for Amniocentesis Needles by End-Use - Hospitals, Diagnostic Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 48: USA Historic Review for Amniocentesis Needles by End-Use - Hospitals, Diagnostic Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 49: USA 16-Year Perspective for Amniocentesis Needles by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
CANADA
TABLE 50: Canada Recent Past, Current & Future Analysis for Amniocentesis Needles by Type - 150 mm & Above, 100 - 150 mm and Below 100 mm - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 51: Canada Historic Review for Amniocentesis Needles by Type - 150 mm & Above, 100 - 150 mm and Below 100 mm Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 52: Canada 16-Year Perspective for Amniocentesis Needles by Type - Percentage Breakdown of Value Sales for 150 mm & Above, 100 - 150 mm and Below 100 mm for the Years 2014, 2024 & 2030
TABLE 53: Canada Recent Past, Current & Future Analysis for Amniocentesis Needles by Procedure - Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion and Cordocentesis - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 54: Canada Historic Review for Amniocentesis Needles by Procedure - Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion and Cordocentesis Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 55: Canada 16-Year Perspective for Amniocentesis Needles by Procedure - Percentage Breakdown of Value Sales for Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion and Cordocentesis for the Years 2014, 2024 & 2030
TABLE 56: Canada Recent Past, Current & Future Analysis for Amniocentesis Needles by End-Use - Hospitals, Diagnostic Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 57: Canada Historic Review for Amniocentesis Needles by End-Use - Hospitals, Diagnostic Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 58: Canada 16-Year Perspective for Amniocentesis Needles by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
JAPAN
Amniocentesis Needles Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 59: Japan Recent Past, Current & Future Analysis for Amniocentesis Needles by Type - 150 mm & Above, 100 - 150 mm and Below 100 mm - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 60: Japan Historic Review for Amniocentesis Needles by Type - 150 mm & Above, 100 - 150 mm and Below 100 mm Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 61: Japan 16-Year Perspective for Amniocentesis Needles by Type - Percentage Breakdown of Value Sales for 150 mm & Above, 100 - 150 mm and Below 100 mm for the Years 2014, 2024 & 2030
TABLE 62: Japan Recent Past, Current & Future Analysis for Amniocentesis Needles by Procedure - Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion and Cordocentesis - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 63: Japan Historic Review for Amniocentesis Needles by Procedure - Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion and Cordocentesis Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 64: Japan 16-Year Perspective for Amniocentesis Needles by Procedure - Percentage Breakdown of Value Sales for Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion and Cordocentesis for the Years 2014, 2024 & 2030
TABLE 65: Japan Recent Past, Current & Future Analysis for Amniocentesis Needles by End-Use - Hospitals, Diagnostic Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 66: Japan Historic Review for Amniocentesis Needles by End-Use - Hospitals, Diagnostic Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 67: Japan 16-Year Perspective for Amniocentesis Needles by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
CHINA
Amniocentesis Needles Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 68: China Recent Past, Current & Future Analysis for Amniocentesis Needles by Type - 150 mm & Above, 100 - 150 mm and Below 100 mm - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 69: China Historic Review for Amniocentesis Needles by Type - 150 mm & Above, 100 - 150 mm and Below 100 mm Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 70: China 16-Year Perspective for Amniocentesis Needles by Type - Percentage Breakdown of Value Sales for 150 mm & Above, 100 - 150 mm and Below 100 mm for the Years 2014, 2024 & 2030
TABLE 71: China Recent Past, Current & Future Analysis for Amniocentesis Needles by Procedure - Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion and Cordocentesis - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 72: China Historic Review for Amniocentesis Needles by Procedure - Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion and Cordocentesis Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 73: China 16-Year Perspective for Amniocentesis Needles by Procedure - Percentage Breakdown of Value Sales for Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion and Cordocentesis for the Years 2014, 2024 & 2030
TABLE 74: China Recent Past, Current & Future Analysis for Amniocentesis Needles by End-Use - Hospitals, Diagnostic Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 75: China Historic Review for Amniocentesis Needles by End-Use - Hospitals, Diagnostic Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 76: China 16-Year Perspective for Amniocentesis Needles by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
EUROPE
Amniocentesis Needles Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 77: Europe Recent Past, Current & Future Analysis for Amniocentesis Needles by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2023 through 2030 and % CAGR
TABLE 78: Europe Historic Review for Amniocentesis Needles by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 79: Europe 16-Year Perspective for Amniocentesis Needles by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
TABLE 80: Europe Recent Past, Current & Future Analysis for Amniocentesis Needles by Type - 150 mm & Above, 100 - 150 mm and Below 100 mm - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 81: Europe Historic Review for Amniocentesis Needles by Type - 150 mm & Above, 100 - 150 mm and Below 100 mm Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 82: Europe 16-Year Perspective for Amniocentesis Needles by Type - Percentage Breakdown of Value Sales for 150 mm & Above, 100 - 150 mm and Below 100 mm for the Years 2014, 2024 & 2030
TABLE 83: Europe Recent Past, Current & Future Analysis for Amniocentesis Needles by Procedure - Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion and Cordocentesis - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 84: Europe Historic Review for Amniocentesis Needles by Procedure - Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion and Cordocentesis Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 85: Europe 16-Year Perspective for Amniocentesis Needles by Procedure - Percentage Breakdown of Value Sales for Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion and Cordocentesis for the Years 2014, 2024 & 2030
TABLE 86: Europe Recent Past, Current & Future Analysis for Amniocentesis Needles by End-Use - Hospitals, Diagnostic Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 87: Europe Historic Review for Amniocentesis Needles by End-Use - Hospitals, Diagnostic Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 88: Europe 16-Year Perspective for Amniocentesis Needles by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
FRANCE
Amniocentesis Needles Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 89: France Recent Past, Current & Future Analysis for Amniocentesis Needles by Type - 150 mm & Above, 100 - 150 mm and Below 100 mm - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 90: France Historic Review for Amniocentesis Needles by Type - 150 mm & Above, 100 - 150 mm and Below 100 mm Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 91: France 16-Year Perspective for Amniocentesis Needles by Type - Percentage Breakdown of Value Sales for 150 mm & Above, 100 - 150 mm and Below 100 mm for the Years 2014, 2024 & 2030
TABLE 92: France Recent Past, Current & Future Analysis for Amniocentesis Needles by Procedure - Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion and Cordocentesis - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 93: France Historic Review for Amniocentesis Needles by Procedure - Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion and Cordocentesis Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 94: France 16-Year Perspective for Amniocentesis Needles by Procedure - Percentage Breakdown of Value Sales for Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion and Cordocentesis for the Years 2014, 2024 & 2030
TABLE 95: France Recent Past, Current & Future Analysis for Amniocentesis Needles by End-Use - Hospitals, Diagnostic Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 96: France Historic Review for Amniocentesis Needles by End-Use - Hospitals, Diagnostic Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 97: France 16-Year Perspective for Amniocentesis Needles by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
GERMANY
Amniocentesis Needles Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 98: Germany Recent Past, Current & Future Analysis for Amniocentesis Needles by Type - 150 mm & Above, 100 - 150 mm and Below 100 mm - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 99: Germany Historic Review for Amniocentesis Needles by Type - 150 mm & Above, 100 - 150 mm and Below 100 mm Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 100: Germany 16-Year Perspective for Amniocentesis Needles by Type - Percentage Breakdown of Value Sales for 150 mm & Above, 100 - 150 mm and Below 100 mm for the Years 2014, 2024 & 2030
TABLE 101: Germany Recent Past, Current & Future Analysis for Amniocentesis Needles by Procedure - Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion and Cordocentesis - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 102: Germany Historic Review for Amniocentesis Needles by Procedure - Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion and Cordocentesis Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 103: Germany 16-Year Perspective for Amniocentesis Needles by Procedure - Percentage Breakdown of Value Sales for Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion and Cordocentesis for the Years 2014, 2024 & 2030
TABLE 104: Germany Recent Past, Current & Future Analysis for Amniocentesis Needles by End-Use - Hospitals, Diagnostic Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 105: Germany Historic Review for Amniocentesis Needles by End-Use - Hospitals, Diagnostic Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 106: Germany 16-Year Perspective for Amniocentesis Needles by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
ITALY
TABLE 107: Italy Recent Past, Current & Future Analysis for Amniocentesis Needles by Type - 150 mm & Above, 100 - 150 mm and Below 100 mm - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 108: Italy Historic Review for Amniocentesis Needles by Type - 150 mm & Above, 100 - 150 mm and Below 100 mm Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 109: Italy 16-Year Perspective for Amniocentesis Needles by Type - Percentage Breakdown of Value Sales for 150 mm & Above, 100 - 150 mm and Below 100 mm for the Years 2014, 2024 & 2030
TABLE 110: Italy Recent Past, Current & Future Analysis for Amniocentesis Needles by Procedure - Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion and Cordocentesis - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 111: Italy Historic Review for Amniocentesis Needles by Procedure - Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion and Cordocentesis Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 112: Italy 16-Year Perspective for Amniocentesis Needles by Procedure - Percentage Breakdown of Value Sales for Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion and Cordocentesis for the Years 2014, 2024 & 2030
TABLE 113: Italy Recent Past, Current & Future Analysis for Amniocentesis Needles by End-Use - Hospitals, Diagnostic Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 114: Italy Historic Review for Amniocentesis Needles by End-Use - Hospitals, Diagnostic Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 115: Italy 16-Year Perspective for Amniocentesis Needles by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
UNITED KINGDOM
Amniocentesis Needles Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 116: UK Recent Past, Current & Future Analysis for Amniocentesis Needles by Type - 150 mm & Above, 100 - 150 mm and Below 100 mm - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 117: UK Historic Review for Amniocentesis Needles by Type - 150 mm & Above, 100 - 150 mm and Below 100 mm Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 118: UK 16-Year Perspective for Amniocentesis Needles by Type - Percentage Breakdown of Value Sales for 150 mm & Above, 100 - 150 mm and Below 100 mm for the Years 2014, 2024 & 2030
TABLE 119: UK Recent Past, Current & Future Analysis for Amniocentesis Needles by Procedure - Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion and Cordocentesis - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 120: UK Historic Review for Amniocentesis Needles by Procedure - Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion and Cordocentesis Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 121: UK 16-Year Perspective for Amniocentesis Needles by Procedure - Percentage Breakdown of Value Sales for Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion and Cordocentesis for the Years 2014, 2024 & 2030
TABLE 122: UK Recent Past, Current & Future Analysis for Amniocentesis Needles by End-Use - Hospitals, Diagnostic Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 123: UK Historic Review for Amniocentesis Needles by End-Use - Hospitals, Diagnostic Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 124: UK 16-Year Perspective for Amniocentesis Needles by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
REST OF EUROPE
TABLE 125: Rest of Europe Recent Past, Current & Future Analysis for Amniocentesis Needles by Type - 150 mm & Above, 100 - 150 mm and Below 100 mm - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 126: Rest of Europe Historic Review for Amniocentesis Needles by Type - 150 mm & Above, 100 - 150 mm and Below 100 mm Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 127: Rest of Europe 16-Year Perspective for Amniocentesis Needles by Type - Percentage Breakdown of Value Sales for 150 mm & Above, 100 - 150 mm and Below 100 mm for the Years 2014, 2024 & 2030
TABLE 128: Rest of Europe Recent Past, Current & Future Analysis for Amniocentesis Needles by Procedure - Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion and Cordocentesis - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 129: Rest of Europe Historic Review for Amniocentesis Needles by Procedure - Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion and Cordocentesis Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 130: Rest of Europe 16-Year Perspective for Amniocentesis Needles by Procedure - Percentage Breakdown of Value Sales for Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion and Cordocentesis for the Years 2014, 2024 & 2030
TABLE 131: Rest of Europe Recent Past, Current & Future Analysis for Amniocentesis Needles by End-Use - Hospitals, Diagnostic Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 132: Rest of Europe Historic Review for Amniocentesis Needles by End-Use - Hospitals, Diagnostic Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 133: Rest of Europe 16-Year Perspective for Amniocentesis Needles by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
ASIA-PACIFIC
Amniocentesis Needles Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 134: Asia-Pacific Recent Past, Current & Future Analysis for Amniocentesis Needles by Type - 150 mm & Above, 100 - 150 mm and Below 100 mm - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 135: Asia-Pacific Historic Review for Amniocentesis Needles by Type - 150 mm & Above, 100 - 150 mm and Below 100 mm Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 136: Asia-Pacific 16-Year Perspective for Amniocentesis Needles by Type - Percentage Breakdown of Value Sales for 150 mm & Above, 100 - 150 mm and Below 100 mm for the Years 2014, 2024 & 2030
TABLE 137: Asia-Pacific Recent Past, Current & Future Analysis for Amniocentesis Needles by Procedure - Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion and Cordocentesis - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 138: Asia-Pacific Historic Review for Amniocentesis Needles by Procedure - Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion and Cordocentesis Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 139: Asia-Pacific 16-Year Perspective for Amniocentesis Needles by Procedure - Percentage Breakdown of Value Sales for Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion and Cordocentesis for the Years 2014, 2024 & 2030
TABLE 140: Asia-Pacific Recent Past, Current & Future Analysis for Amniocentesis Needles by End-Use - Hospitals, Diagnostic Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 141: Asia-Pacific Historic Review for Amniocentesis Needles by End-Use - Hospitals, Diagnostic Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 142: Asia-Pacific 16-Year Perspective for Amniocentesis Needles by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Clinics and Other End-Uses for the Years 2014, 2024 & 2030
REST OF WORLD
TABLE 143: Rest of World Recent Past, Current & Future Analysis for Amniocentesis Needles by Type - 150 mm & Above, 100 - 150 mm and Below 100 mm - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 144: Rest of World Historic Review for Amniocentesis Needles by Type - 150 mm & Above, 100 - 150 mm and Below 100 mm Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 145: Rest of World 16-Year Perspective for Amniocentesis Needles by Type - Percentage Breakdown of Value Sales for 150 mm & Above, 100 - 150 mm and Below 100 mm for the Years 2014, 2024 & 2030
TABLE 146: Rest of World Recent Past, Current & Future Analysis for Amniocentesis Needles by Procedure - Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion and Cordocentesis - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 147: Rest of World Historic Review for Amniocentesis Needles by Procedure - Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion and Cordocentesis Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 148: Rest of World 16-Year Perspective for Amniocentesis Needles by Procedure - Percentage Breakdown of Value Sales for Amniocentesis, Amnioreduction, Fetal Blood Transfusion, Amnioinfusion and Cordocentesis for the Years 2014, 2024 & 2030
TABLE 149: Rest of World Recent Past, Current & Future Analysis for Amniocentesis Needles by End-Use - Hospitals, Diagnostic Centers, Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ for the Years 2023 through 2030 and % CAGR
TABLE 150: Rest of World Historic Review for Amniocentesis Needles by End-Use - Hospitals, Diagnostic Centers, Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ for Years 2014 through 2022 and % CAGR
TABLE 151: Rest of World 16-Year Perspective for Amniocentesis Needles by End-Use - Percentage Breakdown of Value Sales for Hospitals, Diagnostic Centers, Clinics and Other End-Uses for the Years 2014, 2024 & 2030